XML 33 R20.htm IDEA: XBRL DOCUMENT v3.26.1
Investments
3 Months Ended
Feb. 28, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Investments Note 10. InvestmentsInvestments for which we exercise significant influence over the
investee are accounted for under the equity method of
accounting with our shares of the investees’ earnings recognized
in Other revenues. Equity method investments, including any
loans to the investees, are reported within Investments in and
loans to related parties.
$ in millions
February 28,
2026
November 30,
2025
Total Investments in and loans to related
parties ........................................................
$1,560.6
$1,496.1
The following presents summarized financial information about
our significant equity method investees. For certain investees, we
receive financial information on a lag and the summarized
information provided for these investees is based on the latest
financial information available as of February 28, 2026 and 2025.
Three Months Ended February 28,
$ in millions
2026
2025
Total equity method pickup earnings
recognized in Other revenues .................
$24.5
$7.1
Jefferies Finance
Jefferies Finance, our 50/50 joint venture with Massachusetts
Mutual Life Insurance Company (“MassMutual”) structures,
underwrites and syndicates primarily senior secured loans to
corporate borrowers; and manages proprietary and third-party
investments in both broadly syndicated and direct lending loans.
In connection with its Leveraged Finance business, loans are
originated primarily through our investment banking efforts and
Jefferies Finance typically syndicates to third-party investors
substantially all of its arranged volume through us. The Asset
Management business is a multi-strategy private credit platform
that manages proprietary and third-party capital across
commingled funds, funds-of-one, separately managed accounts,
business development companies, CLOs and levered balance
sheet funds. Broadly syndicated loan investments are sourced
through transactions arranged by Jefferies Finance and third-
party arrangers and managed through its subsidiary, Apex Credit
Partners LLC. Direct lending investments are primarily sourced
through us. Jefferies Finance and its subsidiaries that are
involved in investment management are registered investment
advisers with the SEC.
At February 28, 2026, we and MassMutual each had equity
commitments to Jefferies Finance of $750.0 million, for a
combined total commitment of $1.5 billion. The equity
commitment is reduced quarterly based on our share of any
undistributed earnings from Jefferies Finance and the
commitment is increased only to the extent the share of such
earnings are distributed. At February 28, 2026, our unfunded
commitment to Jefferies Finance was $15.4 million. The
investment commitment is scheduled to expire on March 1, 2027
with automatic one year extensions absent a 60 day termination
notice by either party.
Jefferies Finance has executed a secured revolving credit facility
with us and MassMutual, to be funded equally, to support loan
underwritings by Jefferies Finance, which bears interest based on
the interest rates of the related Jefferies Finance underwritten
loans and is secured by the underlying loans funded by the
proceeds of the facility. The total facility is a committed amount
of $500.0 million at February 28, 2026. Advances are shared
equally between us and MassMutual. The facility is scheduled to
mature on March 1, 2027 with automatic one year extensions
absent a 60 day termination notice by either party. At
February 28, 2026, our $250.0 million commitment was undrawn.
Activity related to the facility:
Three Months Ended February 28,
$ in millions
2026
2025
Unfunded commitment fees ........................
$0.3
$0.3
Selected financial information for Jefferies Finance:
$ in millions
February 28,
2026
November 30,
2025
Total assets ....................................................
$6,903.7
$7,356.1
Total liabilities ................................................
5,467.6
5,959.2
Total mezzanine equity .................................
14.9
14.8
$ in millions
February 28,
2026
November 30,
2025
Our total investment balance .......................
$710.6
$691.0
Three Months Ended February 28,
$ in millions
2026
2025
Net earnings (losses) attributable to
members ....................................................
$33.1
$(1.7)
Activity related to our other transactions with Jefferies Finance:
Three Months Ended February 28,
$ in millions
2026
2025
Origination and syndication fee revenues
(1) ...............................................................
$53.1
$60.2
Origination fee expenses (1) ........................
18.6
18.5
CLO placement and structuring fee
revenues (2) .............................................
1.0
0.2
Placement and referral fees (3) ...................
6.3
0.6
Underwriting revenues (expenses) (4) .......
(1.0)
Service fees (5) ..............................................
65.6
54.4
(1)We engage in the origination and syndication of loans underwritten by
Jefferies Finance. In connection with such services, we earned fees, which are
recognized in Investment banking revenues. In addition, we paid fees to
Jefferies Finance in respect of certain loans originated by Jefferies Finance,
which are recognized as Business development expenses.
(2)We act as a placement and/or structuring agent for CLOs managed by
Jefferies Finance, which are recognized as fees and included in Investment
banking revenues.
(3)We act as a placement agent for investment funds managed by Jefferies
Finance, which are recognized as fees and included in Commissions and other
fees.
(4)We act as an underwriter in connection with term loans issued by Jefferies
Finance.
(5)Under a service agreement, we charge Jefferies Finance for various
administrative services provided.
Additional balances with Jefferies Finance as reported in our
Consolidated Statements of Financial Condition.
$ in millions
February 28,
2026
November 30,
2025
Assets
Financial instruments owned, at fair value
(1) .....................................................................
$2.6
$10.9
Other assets (2) .............................................
17.0
7.0
Liabilities
Financial instruments sold, not yet
purchased, at fair value (1) (3) ...............
$7.5
$0.4
Payables:
Brokers, dealers and clearing
organizations (4) ......................................
16.8
17.2
Customers (5) ...........................................
4.8
3.3
(1)In connection with our capital markets activities, from time to time we make a
market in long-term debt securities and term loans of Jefferies Finance (i.e.,
we buy and sell debt securities and tern loans of Jefferies Finance).
(2)Receivable for services and certain fees from Jefferies Finance.
(3)Includes OTC foreign currency derivatives.
(4)Cash collateral received from Jefferies Finance on OTC foreign currency
derivatives.
(5)Payable to Jefferies Finance in connection with loans originated by Jefferies
Finance to borrowers who are investment banking clients of ours. We have
also entered into an agreement to indemnify Jefferies Finance with respect to
any foreign currency exposure on these loans.
Berkadia
Berkadia is a commercial real estate finance and investment
sales joint venture that was formed by us and Berkshire
Hathaway Inc. We are entitled to receive 45.0% of the profits of
Berkadia. Berkadia originates commercial and multifamily real
estate loans that are sold to U.S. government agencies or other
investors with Berkadia retaining the servicing rights. Berkadia
also provides advisory services in connection with sales of
multifamily assets. Berkadia is a servicer of commercial real
estate loans in the U.S., performing primary, master and special
servicing functions for U.S. government agency programs and
financial services companies.
Commercial paper issued by Berkadia is supported by a
$1.50 billion surety policy issued by a Berkshire Hathaway
insurance subsidiary, for which we receive a surety fee, and a
corporate guaranty, and we have agreed to reimburse Berkshire
Hathaway for one-half of any losses incurred thereunder. At
February 28, 2026, the aggregate amount of commercial paper
outstanding was $1.47 billion.
Selected financial information for Berkadia:
$ in millions
February 28,
2026
November 30,
2025
Total assets ...................................................
$5,146.4
$5,269.8
Total liabilities ...............................................
3,686.4
3,953.1
Total noncontrolling interest .......................
521.0
369.0
$ in millions
February 28,
2026
November 30,
2025
Our total investment balance .......................
$426.6
$429.7
Three Months Ended February 28,
$ in millions
2026
2025
Net earnings attributable to members .......
$40.5
$37.8
Three Months Ended February 28,
$ in millions
2026
2025
Distributions ...................................................
$21.2
$16.1
At February 28, 2026 and November 30, 2025, we had
commitments to purchase $13.4 million and $13.6 million,
respectively, of agency CMBS from Berkadia.
Revenues from other transactions with Berkadia for the three
months ended February 28, 2026 and 2025 were $0.0 million and
$0.1 million, respectively.
Real Estate Investments
Our real estate equity method investments primarily consist of
our equity interests in Brooklyn Renaissance Plaza and Hotel and
54 Madison. Brooklyn Renaissance Plaza is composed of a hotel,
office building complex and parking garage located in Brooklyn,
New York. We have a 25.4% equity interest in the hotel and a
61.3% equity interest in the office building and garage. Although
we have a majority interest in the office building and garage, we
do not have control, but only have the ability to exercise
significant influence on this investment. We are amortizing our
basis difference between the estimated fair value and the
underlying book value of Brooklyn Renaissance office building
and garage over the respective useful lives (weighted average life
of 39 years).
We own a 48.1% equity interest in 54 Madison, a fund that most
recently owned an interest in one real estate project and the fund
is in the process of being liquidated.
Selected financial information for the real estate investments:
$ in millions
February 28,
2026
November 30,
2025
Total assets ....................................................
$309.4
$312.6
Total liabilities ................................................
463.7
470.7
February 28,
2026
November 30,
2025
Our total investment balance .......................
$99.5
$98.7
Three Months Ended February 28,
$ in millions
2026
2025
Net earnings ...................................................
$3.8
$4.6
JCP Fund V
We have limited partnership interests of 11% and 50% in Jefferies
Capital Partners V L.P. and Jefferies SBI USA Fund L.P. (together,
JCP Fund V”), respectively, which are private equity funds
managed by a team led by our President and which are in the
process of being fully liquidated. The amount of our investments
in JCP Fund V included in Financial instruments owned, at fair
value was $2.8 million at both February 28, 2026 and
November 30, 2025. We account for these investments at fair
value based on the NAV of the funds provided by the fund
managers. The following summarizes the results from these
investments which are included in Principal transactions
revenues:
Three Months Ended February 28,
$ in millions
2026
2025
Net gains (losses) from our investments
in JCP Fund V ............................................
$
$(0.2)
At both February 28, 2026 and November 30, 2025, we were
committed to invest equity of up to $85.0 million in JCP Fund V.
At both February 28, 2026 and November 30, 2025, our unfunded
commitment relating to JCP Fund V was $8.7 million. We do not
expect any further capital to be called by JCP Fund V.
The following is a summary of the Net change in net assets
resulting from operations for 100.0% of JCP Fund V, in which we
owned effectively 35.1% at February 28, 2026 of the combined
equity interests:
Three Months Ended (1)
$ in millions
December 31,
2025
December 31,
2024
Net increase (decrease) in net assets resulting
from operations .......................................................
$
$(0.6)
(1)Financial information for JCP Fund V within our results of operations for the
three months ended February 28, 2026 and 2025 is included based on the
periods presented.
Hildene
In July 2024, we invested $25.0 million in the Class A Common
Equity Units of Hildene Insurance Holdings, LLC (“Hildene
Insurance”), an investment fund with insurance exposures. On
March 1, 2025, we made an additional investment of
$75.0 million in Hildene Insurance, which resulted in an increase
of our effective ownership from 8.83% to 23.5%. The investment
is accounted for under the equity method with a carrying amount
of $117.1 million and $113.8 million at February 28, 2026 and
November 30, 2025, respectively.
Selected financial information for Hildene Insurance:
$ in millions
December 31,
2025 (1)
September 30,
2025 (1)
Total assets ...............................................................
$564.6
$498.4
Total liabilities ...........................................................
20.1
0.7
Total members’ equity .............................................
544.5
497.7
Three Months Ended (1)
$ in millions
December 31,
2025
December 31,
2024
Net increase in members’ equity resulting from
operations .............................................................
$16.6
$8.4
(1)Financial information for Hildene Insurance Holdings, LLC included in our
financial position at February 28, 2026 and November 30, 2025 is based on
the dates presented, and in our results of operations for the three months
ended February 28, 2026 and 2025 is based on the periods presented.
On December 9, 2025, we entered into an agreement to acquire a
50% interest in Hildene Holding Company, LLC, parent of Hildene
Capital Management, LLC, a credit-focused asset manager and
the parent of Hildene Insurance. We will contribute our existing
revenue share, a portion of our interest in a Hildene-managed
fund, and $340.0 million in cash. Hildene’s principals will
contribute their ownership interests and approximately
$250.0 million of the fund and related equity interests. Closing is
expected in the third quarter of 2026, subject to customary
approvals.
ApiJect
We own shares that represent a 37.9% and 33.6% economic
interest in ApiJect at February 28, 2026 and November 30, 2025,
respectively, which are accounted for at fair value by electing the
fair value option available under U.S. GAAP, and are included
within corporate equity securities in Financial instruments owned,
at fair value. At both February 28, 2026 and November 30, 2025,
the total fair value of our total equity investment in common
shares of ApiJect was $97.9 million, which is classified within
Level 3 of the fair value hierarchy. Additionally, we own warrants
to purchase up to 950,000 shares of common stock at any time
or from time to time on or before April 15, 2032.
We also have a term loan agreement with a principal of ApiJect
for $23.3 million, which matures on April 30, 2026. The loan is
accounted for at amortized cost and is reported within Other
assets. The loan has a fair value of $23.3 million at both
February 28, 2026 and November 30, 2025, which would be
classified as Level 3 in the fair value hierarchy.
In December 2025, we purchased two secured convertible
promissory notes totaling $9.8 million from ApiJect. These
promissory notes are accounted for at fair value in Financial
instruments owned and classified within Level 3 of the fair value
hierarchy.
Aircadia
In December 2023, Aircadia Leasing II LLC (“Aircadia”), a wholly
owned subsidiary, purchased airplanes from one of our clients
and simultaneously entered into a lease with the seller to lease
the airplanes for a term of 42 months. The transaction was
accounted for as a sale leaseback and the airplanes were
recorded within Premises and equipment at $57.7 million. During
the third quarter of 2025, we sold the airplanes.
Three Months Ended February 28,
$ in millions
2026
2025
Operating lease income ................................
$
$5.6
Also in December 2023, we provided a loan to the seller for
$30.0 million, which was paid off on April 1, 2025. The loan was
accounted for at amortized cost and included within Investments
in and loans to related parties. We recognized interest income of
$0.0 million and $0.7 million on the loan during the three months
ended February 28, 2026 and 2025, respectively. We also hold
preferred shares in the seller, which are accounted for at fair
value in Financial instruments owned with a fair value of $43.2
million at both February 28, 2026 and November 30, 2025, and
are classified within Level 3 of the fair value hierarchy.
In September 2024, we provided a €15.0 million loan, maturing in
May 15, 2026, to an individual related to the seller, secured by a
privately owned aircraft and guaranteed by the individual. We
recognized interest income of $0.5 million for both the three
months ended February 28, 2026 and 2025.